Allergan's much-maligned tribal licensing deal wins reprieve at appeals court
admin 29th March 2018 Uncategorised 0Allergan took all kinds of flak for its tribal licensing deal, but an appeals court has breathed new life into the strategy, aimed at protecting its blockbuster eye drug Restasis from early generics.
More: Allergan's much-maligned tribal licensing deal wins reprieve at appeals court
Source: fierce